Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 50/Bag
Request Sample
Manufacturer/Factory

360° Virtual Tour

Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Experienced Team
The supplier has 6 foreign trading staff(s) and 3 staff(s) with over 6 years of overseas trading experience
Patents Awarded
The supplier had awarded 1 patents, you can check the Audit Report for more information
to see all verified strength labels (11)
  • Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic
  • Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic
  • Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic
  • Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic
  • Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic
  • Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic
Find Similar Products

Basic Info.

Model NO.
FLZ-S0911Levetiracetam
Suitable for
Elderly, Children, Adult
State
White Powder
Purity
>99%
Appearance
White Powder
Shelf Life
2 Years
Storage
Keep in Cool and Dry Place
Delivery
Express 5-7 Days Arrive
Test Method
HPLC
Assay
99%
Shipping Area
Worldwide/All Countries
CAS
102767-28-2
Mf
C19h20n6o
MW
348.4
Transport Package
Foil Bag
Specification
99%
Trademark
Xi′an Frazer Biotech Co., Ltd.
Origin
China
Production Capacity
200kg Per Month

Product Description

 Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic
Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic
Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic
 
Specification of Analysis
ITEMS SPECIFICATION TESTRESULTS
Appearance Off-white or white powder Conforms
Identification HPLC,NMR;LC-MS Conforms
Related substances Individual impurity≤0.5% 0.09%
Total impurities≤1.0% 0.20%
Loss on drying ≤0.5% 0.3%
Residue on ignition ≤0.1% 0.04%
Heavy metals ≤10ppm Conforms
Assay ≥98.0 % 99.1%

Levetiracetam has been approved in the United States as add-on treatment for partial (focal), myoclonic, and tonic-clonicseizures. Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case of partial seizures, or as an adjunctive therapy for partial, myoclonic, and tonic-clonic seizures. Levetiracetam has been shown to reduce partial (focal) seizures by 50% or more as an add-on medication.It is also used in veterinary medicine for similar purposes. Based on low-quality evidence, levetiracetam is about as effective as phenytoin for prevention of early seizures after traumatic brain injury.
 

Function & Application:
1) Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case of partial seizures
2) Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome
3) It is also sometimes used to treat neuropathic pain

Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic
Product Name CAS No. Product Name CAS No.
Lufenuron 103055-07-8 Toltrazuril 69004-03-1
Nitenpyram 120738-89-8 Praziquantel/Biltricide 55268-74-1
Fenbendazole 43210-67-9 Tetramisole Hcl 5086-74-8
Levamisole 14769-73-4 Ponazuril 9004-4-2
Diclazuril 101831-37-2 Florfenicol 73231-34-2
Ivermectin 70288-86-7 Enrofloxacin Hcl 112732-17-9
Albendazole 54965-21-8 Mebendazole 31431-39-7

Levetiracetam CAS 102767-28-2 Use for Anti-Epileptic

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier